| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -1.3 | 0.02 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.46 | 0.003 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.4 | 0.03 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.18 | 0.002 |